Shares of Health Care sector company Bristol-Myers Squibb Company moved 1.9% today, and are now trading at a price of $65.92. The large-cap stock's daily volume was 8,463,788 compared to its average volume of 7,886,109. The S&P 500 index returned a -0.0% performance.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company is based in New York and has 34,300 full time employees. Its market capitalization is $138,484,891,648. Bristol-Myers Squibb Company currently offers its equity investors a dividend that yields 3.4% per year.
20 analysts are following Bristol-Myers Squibb Company and have set target prices ranging from $54.41 to $84.85 per share. On average, they have given the company a rating of buy. At today's prices, BMY is trading -10.31% away from its average analyst target price of $73.5 per share.
Over the last year, BMY shares have gone down by -12.3%, which represents a difference of -33.0% when compared to the S&P 500. The stock's 52 week high is $81.44 per share and its 52 week low is $63.07. With average free cash flows of $11.93 Billion that have been growing at an average rate of 13.4% over the last 4 years, Bristol-Myers Squibb Company declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cashflow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2022-12-31 | 13,066,000 | -1,118,000 | 11,948,000 | -21.57 |
| 2021-12-31 | 16,207,000 | -973,000 | 15,234,000 | 14.55 |
| 2020-12-31 | 14,052,000 | -753,000 | 13,299,000 | 83.92 |
| 2019-12-31 | 8,067,000 | -836,000 | 7,231,000 | n/a |
